Telix Pharmaceuticals Ltd has released a press release.
Prostate Imaging Program - Commercial and Regulatory Update
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Telix Pharmaceuticals
- Appendix 4C - March 2019 Quarter
- Fractionated Prostate Cancer Therapy Published
- Non-Deal Roadshow Presentation March-April 2019
- Appendix 4C - December 2018 quarter
- Telix Group Expands Prostate Imaging Capability through ININ
Later from Telix Pharmaceuticals
- Telix and Osaka University Extend Collaboration
- Telix and Monrol Manufacturing and Distribution Agreement
- Telix Reports Positive Phase III Meeting with the FDA
- Telix announces completion of $40.0 million Placement
- Investor Presentation
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals